Suvemcitug combined with chemotherapy significantly improved PFS and OS in platinum-resistant recurrent ovarian cancer, nearly doubling median PFS and extending median OS. The trial demonstrated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback